3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
2
Thoracic
1
Genitourinary
1
Breast
1
Conditions
Lung Neoplasms
2
Venous Thromboembolism
1
Thrombosis
1
Thromboembolism
1
Prostatic Neoplasms
1
Neoplasms
1
Inflammation
1
Immune System Diseases
1
Colonic Neoplasms
1
Cardiovascular Diseases
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Hepatocellular
1
Breast Neoplasms
1
Interventions
pembrolizumab
12
Gemcitabine
9
Cetuximab
7
Psychiatric Rehabilitation
6
Paclitaxel
6
Magnetic Resonance Spectroscopy
6
Fluorouracil
6
Early Intervention, Educational
6
Cisplatin
6
cediranib
5
Leucovorin
5
Carboplatin
5
sargramostim
4
Standard of Care
4
Oxaliplatin
4
Methods
4
Erlotinib Hydrochloride
4
Docetaxel
4
Cyclophosphamide
4
selpercatinib
3
aldesleukin
3
adagrasib
3
Trastuzumab
3
Therapeutics
3
Pemetrexed
3
Nivolumab
3
Irinotecan
3
Fluorodeoxyglucose F18
3
Bortezomib
3
Bevacizumab
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Colonic Neoplasms
×
Rivaroxaban
×
Thoracic
×
Clear all
NCT06065592
2023-10-06
CAT_PB
Lebanese University
Phase 1
Unknown
500 enrolled